UiPath's Agentic AI Targets RCM's Three Hardest Problems

UiPath launched an agentic AI suite for medical records review, denial management, and prior authorization. Medlitix reported a 90% reduction in summary review time — from 70 minutes to six. Here's what it means for RCM teams.

The announcement is notable less for the technology itself — AI-assisted summarization and denial workflows have been in vendor roadmaps for two years — and more for the benchmark data attached to it.

That figure, if reproducible at scale, changes the calculus for clinical documentation review teams. Most prior auth denials involving medical necessity sit in a review queue for days before a human touches it. Cutting that step from 70 to 6 minutes doesn't just reduce cost — it compresses the cycle time between submission and appeal.

"Since implementing the UiPath MRS solution, we've reduced the average summary review time from 70 minutes to six, a 90 per cent improvement. Our clinicians are spending more time on direct patient care and less time digging through documentation."

— Benjamin Smith, VP of Technology, Medlitix

What the Three Products Actually Do

Medical Records Summarization: Structured output with citations traceable back to source documents. The design choice here — traceability — is what distinguishes it from a generic summarization tool. In a denial appeal, you need to cite the specific clinical record that supports medical necessity. A summary that can't do that isn't usable in the revenue cycle context.